Literature DB >> 22435564

Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer.

Albert S Baldwin1.   

Abstract

The cellular response to survive or to undergo death is fundamental to the benefit of the organism, and errors in this process can lead to autoimmunity and cancer. The transcription factor nuclear factor κB (NF-κB) functions to block cell death through transcriptional induction of genes encoding anti-apoptotic and antioxidant proteins. This is essential for survival of activated cells of the immune system and for cells undergoing a DNA damage response. In Ras-transformed cells and tumors as well as other cancers, NF-κB functions to suppress apoptosis--a hallmark of cancer. Critical prosurvival roles for inhibitor of NF-κB kinase (IKK) family members, including IKKε and TBK1, have been reported, which are both NF-κB-dependent and -independent. While the roles of NF-κB in promoting cell survival in lymphocytes and in cancers is relatively clear, evidence has been presented that NF-κB can promote cell death in particular contexts. Recently, IKK was shown to play a critical role in the induction of autophagy, a metabolic response typically associated with cell survival but which can lead to cell death. This review provides an historical perspective, along with new findings, regarding the roles of the IKK and NF-κB pathways in regulating cell survival.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22435564     DOI: 10.1111/j.1600-065X.2012.01095.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  114 in total

1.  TBK1 regulates prostate cancer dormancy through mTOR inhibition.

Authors:  Jin Koo Kim; Younghun Jung; Jingcheng Wang; Jeena Joseph; Anjali Mishra; Elliott E Hill; Paul H Krebsbach; Kenneth J Pienta; Yusuke Shiozawa; Russell S Taichman
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

Review 2.  TLR-4 Signaling vs. Immune Checkpoints, miRNAs Molecules, Cancer Stem Cells, and Wingless-Signaling Interplay in Glioblastoma Multiforme-Future Perspectives.

Authors:  Jakub Litak; Cezary Grochowski; Joanna Litak; Ida Osuchowska; Krzysztof Gosik; Elżbieta Radzikowska; Piotr Kamieniak; Jacek Rolinski
Journal:  Int J Mol Sci       Date:  2020-04-28       Impact factor: 5.923

3.  Survivin Inhibitors Mitigate Chemotherapeutic Resistance in Breast Cancer Cells by Suppressing Genotoxic Nuclear Factor-κB Activation.

Authors:  Wei Wang; Bo Zhang; Arul M Mani; Zhongzhi Wu; Yu Fan; Wei Li; Zhao-Hui Wu
Journal:  J Pharmacol Exp Ther       Date:  2018-05-07       Impact factor: 4.030

4.  IKK phosphorylates RelB to modulate its promoter specificity and promote fibroblast migration downstream of TNF receptors.

Authors:  Hélène Authier; Katy Billot; Emmanuel Derudder; Didier Bordereaux; Pierre Rivière; Sylvie Rodrigues-Ferreira; Clara Nahmias; Véronique Baud
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

Review 5.  NF-κB signaling pathway and its potential as a target for therapy in lymphoid neoplasms.

Authors:  Li Yu; Ling Li; L Jeffrey Medeiros; Ken H Young
Journal:  Blood Rev       Date:  2016-10-13       Impact factor: 8.250

Review 6.  Advances in targeted therapy for malignant lymphoma.

Authors:  Li Wang; Wei Qin; Yu-Jia Huo; Xiao Li; Qing Shi; John E J Rasko; Anne Janin; Wei-Li Zhao
Journal:  Signal Transduct Target Ther       Date:  2020-03-06

7.  Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.

Authors:  Yinghui Li; Qi-Ling Zhou; Wenjie Sun; Prashant Chandrasekharan; Hui Shan Cheng; Zhe Ying; Manikandan Lakshmanan; Anandhkumar Raju; Daniel G Tenen; Shi-Yuan Cheng; Kai-Hsiang Chuang; Jun Li; Shyam Prabhakar; Mengfeng Li; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2015-09-21       Impact factor: 28.824

8.  Regulation of anoikis by deleted in breast cancer-1 (DBC1) through NF-κB.

Authors:  Sun Hee Park; Philip Riley; Steven M Frisch
Journal:  Apoptosis       Date:  2013-08       Impact factor: 4.677

9.  Akt-dependent activation of mTORC1 complex involves phosphorylation of mTOR (mammalian target of rapamycin) by IκB kinase α (IKKα).

Authors:  Han C Dan; Aaron Ebbs; Manolis Pasparakis; Terry Van Dyke; Daniela S Basseres; Albert S Baldwin
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

10.  A non-SUMOylated tax protein is still functional for NF-κB pathway activation.

Authors:  Sabrina Pène; Laetitia Waast; Amandine Bonnet; Laurence Bénit; Claudine Pique
Journal:  J Virol       Date:  2014-07-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.